Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -33.92% is 174% below its 5-year average of -12.37%, near the high end of its 5-year range (-2472.48%–13.57%).
93.34% above its 12-month average of -509.48%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -2472.48%.
NET PROFIT MARGIN
-33.92%
NET PROFIT MARGIN AVG TTM
-509.48%
NET PROFIT MARGIN AVG 3Y
-14.65%
NET PROFIT MARGIN AVG 5Y
-12.37%
NET PROFIT MARGIN AVG 10Y
-9.72%
NET PROFIT MARGIN AVG 15Y
-4.87%
NET PROFIT MARGIN AVG 20Y
-0.92%
CURRENT VS TTM AVG
+93.34%
CURRENT VS 3Y AVG
-131.56%
CURRENT VS 5Y AVG
-174.11%
CURRENT VS 10Y AVG
-249.02%
CURRENT VS 15Y AVG
-596.66%
CURRENT VS 20Y AVG
-3570.15%
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 678 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Cumberland Pharmaceuticals Inc.
Market Cap
$107.80M
Net Profit Margin
-33.92%
TTM Avg
-509.48%
3Y Avg
-14.65%
5Y Avg
-12.37%
Market Cap
$108.32M
Net Profit Margin
-14.78%
TTM Avg
-35.00%
3Y Avg
-39.46%
5Y Avg
-38.67%
Market Cap
$108.94M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-1332.08%
Market Cap
$109.99M
Net Profit Margin
-4416.22%
TTM Avg
-2208.11%
3Y Avg
-1104.06%
5Y Avg
-736.04%
Market Cap
$110.31M
Net Profit Margin
31.95%
TTM Avg
15.97%
3Y Avg
7.99%
5Y Avg
5.33%
Market Cap
$105.02M
Net Profit Margin
-72.28%
TTM Avg
-110.67%
3Y Avg
-76.27%
5Y Avg
-63.46%
Market Cap
$104.68M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$110.95M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cumberland Pharmaceuticals Inc. (CPIX) | $107.80M | -33.92% | -509.48% | -14.65% | -12.37% |
| Apyx Medical Corporation (APYX)vs › | $108.32M | -14.78% | -35.00% | -39.46% | -38.67% |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP)vs › | $108.94M | 0.00% | 0.00% | 0.00% | -1332.08% |
| Outlook Therapeutics, Inc. (OTLK)vs › | $109.99M | -4416.22% | -2208.11% | -1104.06% | -736.04% |
| Immunic, Inc. (IMUX)vs › | $110.33M | 0.00% | 0.00% | 0.00% | 0.00% |
| Black Diamond Therapeutics, Inc. (BDTX)vs › | $110.31M | 31.95% | 15.97% | 7.99% | 5.33% |
| Definitive Healthcare Corp. (DH)vs › | $105.02M | -72.28% | -110.67% | -76.27% | -63.46% |
| Polaryx Therapeutics, Inc. Common Stock (PLYX)vs › | $104.68M | 0.00% | 0.00% | 0.00% | 0.00% |
| Aardvark Therapeutics, Inc. Common Stock (AARD)vs › | $110.95M | 0.00% | 0.00% | 0.00% | 0.00% |
| BGM Group Ltd. (BGM)vs › | $111.14M | -52.59% | -29.17% | -18.36% | -9.63% |
Operating Margin
-6.3%
Net Profit Margin
-33.9%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -2472.48% |
| 2026-03-31 | -34.37% |
| 2025-12-31 | -10.32% |
| 2025-09-30 | -23.40% |
| 2025-06-30 | -6.84% |
| 2025-03-31 | 10.73% |
| 2024-12-31 | -18.24% |
| 2024-09-30 | -16.99% |
| 2024-06-30 | -11.02% |
| 2024-03-31 | -22.90% |
| 2023-12-31 | -67.30% |
| 2023-09-30 | -10.40% |
| 2023-06-30 | 8.01% |
| 2023-03-31 | 2.08% |
| 2022-12-31 | -26.75% |
| 2022-09-30 | -3.58% |
| 2022-06-30 | -12.97% |
| 2022-03-31 | -12.40% |
| 2021-12-31 | -46.25% |
| 2021-09-30 | -13.07% |
| 2021-06-30 | 13.57% |
| 2021-03-31 | 1.58% |
| 2020-12-31 | -8.61% |
| 2020-09-30 | -5.21% |
| 2020-06-30 | -9.57% |
| 2020-03-31 | -12.67% |
| 2019-12-31 | -7.02% |
| 2019-09-30 | -18.84% |
| 2019-06-30 | -4.75% |
| 2019-03-31 | -0.62% |
| 2018-12-31 | -16.45% |
| 2018-09-30 | -19.35% |
| 2018-06-30 | -7.09% |
| 2018-03-31 | -27.71% |
| 2017-12-31 | -6.87% |
| 2017-09-30 | -6.64% |
| 2017-06-30 | -59.54% |
| 2017-03-31 | -13.22% |
| 2016-12-31 | -8.26% |
| 2016-09-30 | 1.21% |
| 2016-06-30 | -0.65% |
| 2016-03-31 | -3.27% |
| 2015-12-31 | 1.88% |
| 2015-09-30 | 1.61% |
| 2015-06-30 | 4.56% |
| 2015-03-31 | 0.53% |
| 2014-12-31 | 7.17% |
| 2014-09-30 | 7.67% |
| 2014-06-30 | 7.41% |
| 2014-03-31 | 3.54% |
| 2013-12-31 | -18.39% |
| 2013-09-30 | -12.56% |
| 2013-06-30 | -9.02% |
| 2013-03-31 | 8.33% |
| 2012-12-31 | 13.18% |
| 2012-09-30 | 14.92% |
| 2012-06-30 | 14.10% |
| 2012-03-31 | 4.13% |
| 2011-12-31 | 7.00% |
| 2011-09-30 | 14.15% |
| 2011-06-30 | 15.13% |
| 2011-03-31 | 6.76% |
| 2010-12-31 | 6.54% |
| 2010-09-30 | 8.27% |
| 2010-06-30 | 2.68% |
| 2010-03-31 | 3.19% |
| 2009-12-31 | 2.70% |
| 2009-09-30 | 9.47% |
| 2009-06-30 | 3.01% |
| 2009-03-31 | 12.95% |
| 2008-12-31 | 11.25% |
| 2008-09-30 | 14.05% |
| 2008-06-30 | 12.66% |
| 2008-03-31 | 16.80% |
| 2007-12-31 | 10.96% |
| 2007-09-30 | 16.91% |
| 2007-06-30 | 16.92% |
| 2007-03-31 | 12.51% |
| 2006-12-31 | 57.66% |
| 2006-09-30 | 26.44% |
| 2006-06-30 | 13.20% |
| 2006-03-31 | -87.67% |
